At the level of transcriptional and enzymatic regulation, glutathione S-transferase A1 (GSTA1) and β-catenin (CTNNB1) have been identified as key drivers of ferroptosis resistance, particularly in sorafenib-treated hepatocellular carcinoma. The gene discussed is GSTA1; the disease is hepatocellular carcinoma.